Gelonghui, December 28 | 1. Guangyang Co., Ltd.: In order to further promote the development of the electronic circuit board business and accelerate the layout of the automotive electronics industry chain, the company will increase its capital by a total of 200 million yuan through capital increase and share expansion. Among them, the company plans to partially relinquish priority subscription rights and increase capital by 145 million yuan (of which 100 million yuan of debt is converted into equity). The company's employee shareholding platform Shihui Investment plans to increase capital by 2.5 million yuan. The capital of the investor investment parent fund introduced this time was increased by 50 million yuan. After the capital increase was completed, the shareholding ratio of Koyo Co., Ltd. changed from 84.9802% to 79.4702%. 2. Tianyi Medical: The company recently received the “Medical Device Registration Certificate” for dry hemodialysis powder issued by the State Drug Administration. This product is suitable for hemodialysis treatment of patients with acute and chronic renal failure. 3. Infineon: The company received a decision on administrative supervision measures delivered by the Shenzhen Securities Regulatory Bureau on December 28. After investigation, the company had problems with inaccurate disclosure of financial reports and inconsistent and continuous disclosure of voluntary information. The Shenzhen Securities Regulatory Bureau decided to take corrective administrative supervision measures against the company.